FIIO's vacuum tube integrated amplifier, the "EA13," will be released on October 9th. This is a memo to help me decide whether to place this amplifier, which is expected to cost around 132,000 yen, in ...

In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.

Presenter: Professor Lung-Yi Loey Mak, MBBS (HK), MD (HK), MRCP ( UK ), PDipID (HK), FHKCP, FHKAM (Medicine), FRCP (Glasg), FRCP (Edin), FRCP, Clinical Assistant Professor at The University of Hong ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced participation in the upcoming AASLD Liver Meeting 2026. The Company ...

FleishmanHillard and Contagious today released a new study, "The Chaos Advantage," examining how the world's most successful ...

Enfortumab vedotin plus pembrolizumab presentations include the longest follow-up reported to date in locally advanced or metastatic urothelial cancer, along with analyses across patient subgroups and ...

Monte Rosa Therapeutics (NASDAQ:GLUE) reported results from GFORCE-1, a Phase I study of its NEK7-directed molecular glue ...

F2G Ltd. today announced abstracts accepted for oral and poster presentation at IDWeek 2026, taking place October 212 ...

First clinical data for CPV-104 in patients, including interim safety, tolerability and pharmacokinetics, accepted as a ...

Risumaru, currently challenging the Management Business Chief exam!This time, I'm stepping away from the Civil Code I've been ...